Terns Pharmaceuticals Inc
NASDAQ:TERN
Terns Pharmaceuticals Inc
NASDAQ:TERN
Price:
52.62
USD
-0.3%
Market Cap:
$5.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
Xelpmoc Design and Tech Ltd
NSE:XELPMOC
|
IN |
|
F
|
Fielmann Group AG
XMUN:FIE
|
DE |
Balance Sheet
Balance Sheet Decomposition
Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc
Balance Sheet
Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
83
|
12
|
75
|
48
|
143
|
80
|
161
|
525
|
|
| Cash |
0
|
0
|
0
|
15
|
120
|
46
|
14
|
24
|
|
| Cash Equivalents |
83
|
12
|
75
|
33
|
23
|
34
|
148
|
501
|
|
| Short-Term Investments |
4
|
7
|
0
|
118
|
140
|
184
|
197
|
494
|
|
| Total Receivables |
0
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
3
|
3
|
1
|
2
|
4
|
4
|
5
|
|
| Total Current Assets |
89
|
22
|
91
|
167
|
285
|
267
|
362
|
1 024
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
89
N/A
|
24
-73%
|
92
+286%
|
168
+82%
|
287
+71%
|
269
-6%
|
364
+36%
|
1 025
+182%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
2
|
1
|
2
|
2
|
3
|
2
|
2
|
|
| Accrued Liabilities |
1
|
3
|
9
|
4
|
7
|
9
|
13
|
14
|
|
| Short-Term Debt |
0
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
5
|
23
|
7
|
9
|
12
|
16
|
16
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
14
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
|
| Total Liabilities |
17
N/A
|
20
+17%
|
24
+20%
|
8
-67%
|
10
+29%
|
13
+30%
|
18
+37%
|
19
+3%
|
|
| Equity | |||||||||
| Common Stock |
95
|
95
|
186
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
23
|
92
|
132
|
182
|
242
|
333
|
421
|
518
|
|
| Additional Paid In Capital |
1
|
1
|
15
|
343
|
520
|
588
|
768
|
1 524
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
72
N/A
|
4
-94%
|
69
+1 533%
|
160
+134%
|
277
+73%
|
255
-8%
|
346
+35%
|
1 007
+191%
|
|
| Total Liabilities & Equity |
89
N/A
|
24
-73%
|
92
+286%
|
168
+82%
|
287
+71%
|
269
-6%
|
364
+36%
|
1 025
+182%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
23
|
23
|
23
|
25
|
54
|
65
|
87
|
112
|
|
Switch to:
Switch to:
See Also
Discover More
